Vista Pharmaceuticals Limited (VISTAPH.BO)
INR 11.15
(1.09%)
INR 11.15
(1.09%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 102.87 Million INR | 924.99% |
| 2022 | 10.03 Million INR | 154.36% |
| 2021 | 3.94 Million INR | -68.84% |
| 2020 | 12.66 Million INR | -94.44% |
| 2019 | 227.59 Million INR | -26.76% |
| 2018 | 310.72 Million INR | 10.12% |
| 2017 | 282.17 Million INR | 16.69% |
| 2016 | 241.81 Million INR | 57.23% |
| 2015 | 153.79 Million INR | 11.88% |
| 2014 | 137.46 Million INR | 65.59% |
| 2013 | 83.01 Million INR | 11.15% |
| 2012 | 74.68 Million INR | 106.19% |
| 2011 | 36.22 Million INR | -36.16% |
| 2010 | 56.74 Million INR | 608.07% |
| 2009 | 8.01 Million INR | -56.04% |
| 2008 | 18.23 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 17.95 Million INR | -42.7% |
| 2023 Q3 | 17.04 Million INR | -50.88% |
| 2023 FY | 102.87 Million INR | 924.99% |
| 2023 Q4 | 31.32 Million INR | 83.78% |
| 2023 Q2 | 34.69 Million INR | 75.15% |
| 2023 Q1 | 19.81 Million INR | 97.37% |
| 2022 Q3 | - INR | 0.0% |
| 2022 FY | 10.03 Million INR | 154.36% |
| 2022 Q4 | 10.03 Million INR | 0.0% |
| 2022 Q2 | - INR | 0.0% |
| 2022 Q1 | - INR | 100.0% |
| 2021 Q2 | 2.85 Million INR | 0.0% |
| 2021 FY | 3.94 Million INR | -68.84% |
| 2021 Q4 | -1000.00 INR | -100.09% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | 1.09 Million INR | -61.74% |
| 2020 Q4 | 4.76 Million INR | 24.64% |
| 2020 FY | 12.66 Million INR | -94.44% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 4.08 Million INR | 0.0% |
| 2020 Q3 | 3.81 Million INR | -6.51% |
| 2019 Q3 | 67.29 Million INR | -16.87% |
| 2019 Q4 | 8.11 Million INR | -87.94% |
| 2019 FY | 227.59 Million INR | -26.76% |
| 2019 Q1 | 71.23 Million INR | -41.52% |
| 2019 Q2 | 80.94 Million INR | 13.64% |
| 2018 Q4 | 121.81 Million INR | 73.66% |
| 2018 FY | 310.72 Million INR | 10.12% |
| 2018 Q2 | 58.8 Million INR | -1.94% |
| 2018 Q1 | 59.96 Million INR | -15.63% |
| 2018 Q3 | 70.14 Million INR | 19.29% |
| 2017 Q2 | 66.99 Million INR | -8.16% |
| 2017 FY | 282.17 Million INR | 16.69% |
| 2017 Q4 | 71.07 Million INR | -0.11% |
| 2017 Q3 | 71.15 Million INR | 6.22% |
| 2017 Q1 | 72.94 Million INR | 19.28% |
| 2016 Q1 | 58.15 Million INR | 0.56% |
| 2016 Q4 | 61.15 Million INR | -2.82% |
| 2016 Q3 | 62.92 Million INR | 5.62% |
| 2016 Q2 | 59.57 Million INR | 2.44% |
| 2016 FY | 241.81 Million INR | 57.23% |
| 2015 Q4 | 57.83 Million INR | 19.76% |
| 2015 FY | 153.79 Million INR | 11.88% |
| 2015 Q1 | 14.39 Million INR | -42.74% |
| 2015 Q2 | 33.27 Million INR | 131.17% |
| 2015 Q3 | 48.29 Million INR | 45.15% |
| 2014 Q4 | 25.13 Million INR | -50.33% |
| 2014 FY | 137.46 Million INR | 65.59% |
| 2014 Q1 | 30.97 Million INR | -42.98% |
| 2014 Q2 | 30.74 Million INR | -0.72% |
| 2014 Q3 | 50.6 Million INR | 64.58% |
| 2013 Q1 | 8.81 Million INR | -50.39% |
| 2013 FY | 83.01 Million INR | 11.15% |
| 2013 Q4 | 54.31 Million INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 19.88 Million INR | 125.54% |
| 2012 Q1 | 21.48 Million INR | 40.99% |
| 2012 FY | 74.68 Million INR | 106.19% |
| 2012 Q4 | 17.77 Million INR | 3.66% |
| 2012 Q3 | 17.14 Million INR | -6.29% |
| 2012 Q2 | 18.29 Million INR | -14.84% |
| 2011 FY | 36.22 Million INR | -36.16% |
| 2011 Q3 | 5.09 Million INR | 0.0% |
| 2011 Q4 | 15.23 Million INR | 199.16% |
| 2010 FY | 56.74 Million INR | 608.07% |
| 2010 Q4 | 26.13 Million INR | 0.0% |
| 2009 Q4 | - INR | 0.0% |
| 2009 FY | 8.01 Million INR | -56.04% |
| 2008 Q4 | - INR | 0.0% |
| 2008 FY | 18.23 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Add-Shop E-Retail Limited | 2.02 Billion INR | 94.909% |
| Cian Healthcare Limited | 616.95 Million INR | 83.325% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -459.667% |
| Colinz Laboratories Limited | 70.29 Million INR | -46.35% |
| Denis Chem Lab Limited | 1.67 Billion INR | 93.87% |
| Emmessar Biotech & Nutrition Limited | 5.55 Million INR | -1752.99% |
| Evoq Remedies Limited | 63.09 Million INR | -63.065% |
| Gujarat Themis Biosyn Limited | 1.69 Billion INR | 93.942% |
| Jenburkt Pharmaceuticals Limited | 1.41 Billion INR | 92.753% |
| MedPlus Health Services Limited | 56.24 Billion INR | 99.817% |
| OXYGENTA PHARMACEUTICAL LIMITE | 396.42 Million INR | 74.048% |
| PANJON LTD. | 125.52 Million INR | 18.039% |
| PRAVEG LIMITED | 915.96 Million INR | 88.768% |
| Sanjivani Paranteral Limited. | 536.87 Million INR | 80.837% |
| Sastasundar Ventures Limited | 13.56 Billion INR | 99.241% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.11 Million INR | -9101.968% |
| SHELTER PHARMA LIMITED | 400.22 Million INR | 74.295% |
| BDH Industries Limited | 858.31 Million INR | 88.014% |
| DECIPHER LABS LIMITED | 362.75 Million INR | 71.64% |
| ANG Lifesciences India Limited | 1.46 Billion INR | 92.959% |
| Veerhealth Care Limited | 142.13 Million INR | 27.619% |
| Zenith Healthcare Limited | 144.71 Million INR | 28.911% |
| Zenlabs Ethica Limited | 585.63 Million INR | 82.433% |
| Zenotech Laboratories Limited | 368.08 Million INR | 72.051% |
| Crestchem Limited | 212.56 Million INR | 51.601% |
| Norris Medicines Limited | 56.35 Million INR | -82.55% |
| Shukra Pharmaceuticals Limited | 745.72 Million INR | 86.204% |
| Sunil Healthcare Limited | 901.91 Million INR | 88.593% |
| Ambalal Sarabhai Enterprises Limited | 1.74 Billion INR | 94.099% |
| Bacil Pharma Limited | - INR | -Infinity% |
| Fredun Pharmaceuticals Limited | 3.48 Billion INR | 97.045% |
| Patidar Buildcon Limited | 2.3 Million INR | -4357.452% |
| Phaarmasia Limited | 305.93 Million INR | 66.372% |
| Shree Ganesh Remedies Limited | 1.25 Billion INR | 91.828% |
| SUDARSHAN PHARMA INDUSTRIES LI | 4.63 Billion INR | 97.781% |
| Trimurthi Limited | 42.23 Million INR | -143.567% |
| Vivanza Biosciences Limited | 278.89 Million INR | 63.112% |
| Hindustan Bio Sciences Limited | 10.48 Million INR | -880.768% |
| Anuh Pharma Limited | 6.47 Billion INR | 98.41% |
| Beryl Drugs Limited | 271.24 Million INR | 62.072% |
| Bharat Immunologicals & Biologicals Corporation Limited | 446.09 Million INR | 76.938% |
| Deccan Health Care Limited | 597.28 Million INR | 82.776% |
| Godavari Drugs Limited | 1.56 Billion INR | 93.435% |
| Gujarat Terce Laboratories Limited | 479.74 Million INR | 78.556% |
| Ishita Drugs and Industries Limited | 151.87 Million INR | 32.262% |
| Kerala Ayurveda Limited | 1.02 Billion INR | 89.947% |
| KIMIA BIOSCIENCES LIMITED | 1.04 Billion INR | 90.191% |
| Lactose (India) Limited | 1.13 Billion INR | 90.967% |
| Makers Laboratories Limited | 1.03 Billion INR | 90.085% |
| Medi-Caps Limited | 265.63 Million INR | 61.271% |
| Mercury Laboratories Limited | 755.59 Million INR | 86.384% |
| Parmax Pharma Limited | 154.24 Million INR | 33.302% |
| Roopa Industries Limited | 715.53 Million INR | 85.622% |
| Smruthi Organics Limited | 1.27 Billion INR | 91.94% |
| Source Natural Foods and Herbal Supplements Limited | 272.96 Million INR | 62.311% |
| Syschem (India) Limited | 2.33 Billion INR | 95.595% |
| Vikram Thermo (India) Limited | 1.25 Billion INR | 91.797% |
| Bharat Parenterals Limited | 2.59 Billion INR | 96.034% |
| Trident Lifeline Limited | 446.28 Million INR | 76.948% |
| Concord Drugs Limited | 449.24 Million INR | 77.1% |
| Gennex Laboratories Limited | 867.14 Million INR | 88.136% |
| TIAAN CONSUMER LIMITED | - INR | -Infinity% |
| Vasundhara Rasayans Limited | 370.18 Million INR | 72.209% |
| Parnax Lab Limited | 1.88 Billion INR | 94.548% |
| Trinity League India Limited | 2.95 Million INR | -3387.39% |
| Sandu Pharmaceuticals Limited | 672.8 Million INR | 84.709% |
| Tyche Industries Limited | 696.83 Million INR | 85.236% |
| Kwality Pharmaceuticals Limited | 3.07 Billion INR | 96.651% |
| Transchem Limited | 4.09 Million INR | -2409.22% |
| Pharmaids Pharmaceuticals Limited | 151.12 Million INR | 31.923% |
| Panchsheel Organics Limited | 1.05 Billion INR | 90.222% |
| Coral Laboratories Limited | 836.6 Million INR | 87.703% |
| KOBO BIOTECH LIMITED | - INR | -Infinity% |
| Natural Capsules Limited | 1.55 Billion INR | 93.381% |
| Auro Laboratories Limited | 526.99 Million INR | 80.478% |